C4X Discovery Share Forecast, Price & News

GBX 31.50
+0.38 (+1.22 %)
(As of 08/3/2021 12:00 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume37,925 shs
Average Volume482,201 shs
Market Capitalization£71.41 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive C4XD News and Ratings via Email

Sign-up to receive the latest news and ratings for C4X Discovery and its competitors with MarketBeat's FREE daily newsletter.

About C4X Discovery

C4X Discovery Holdings plc operates as a drug discovery and development company in the United Kingdom. It has a suite of proprietary technologies across the drug discovery process, including Taxonomy3, a novel in silico platform technology that utilizes proprietary mathematical algorithms to perform complex multivariate analysis of genetic data; Conformetrix, a technology platform which allows 3D-shapes of free drug molecules to be measured from experimental data, giving medicinal chemists new and unprecedented insights into the behavior and physical properties of drug molecules; and 4Sight for visualizing and designing 4D molecules in virtual reality. The company's product pipeline comprises Oral Orexin-1, an antagonist for the treatment of substance abuse disorders; Oral NRF-2 activators, IL-17 inhibitors, and a4Ã7 integrin inhibitors for the treatment of inflammatory diseases; MALT-1 inhibitors for the treatment of hematological cancer; synthetic lethal novel targets for the treatment of colorectal and lung cancer; and various products for the treatment of neurodegenerative diseases. It has research collaboration agreements with the University of Bristol, the University of Reading, the University of Oxford, and the University of Manchester; and drug discovery partnerships with Indivior PLC, LifeArc, GTN LTD, PhoreMost, e-therapeutics plc, AstraZeneca UK Limited, Evotec, SGC-Oxford, and Horizon Discovery Ltd. The company was formerly known as Schosween 24 plc and changed its name to C4X Discovery Holdings plc October 2014. C4X Discovery Holdings plc was founded in 2007 and is based in Manchester, the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

1.00 out of 5 stars

Analyst Opinion: 0.0Community Rank: 5.0Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

C4X Discovery (LON:C4XD) Frequently Asked Questions

What stocks does MarketBeat like better than C4X Discovery?

Wall Street analysts have given C4X Discovery a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but C4X Discovery wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

How were C4X Discovery's earnings last quarter?

C4X Discovery Holdings plc (LON:C4XD) issued its quarterly earnings results on Wednesday, April, 29th. The company reported ($5.02) earnings per share for the quarter, topping the Thomson Reuters' consensus estimate of ($5.50) by $0.48.
View C4X Discovery's earnings history

How has C4X Discovery's stock been impacted by COVID-19 (Coronavirus)?

C4X Discovery's stock was trading at GBX 9.75 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, C4XD stock has increased by 223.1% and is now trading at GBX 31.50.
View which stocks have been most impacted by COVID-19

Who are C4X Discovery's key executives?

C4X Discovery's management team includes the following people:
  • Dr. Clive James Dix, CEO & Director (Age 66, Pay $162k)
  • Mr. Bradley Richard Hoy, CFO, Sec. & Director (Age 58, Pay $153k)
  • Dr. Justian Craig Fox, Chief Scientific Officer & Director (Age 46, Pay $147k)
  • Ms. Bhavna Hunjan, Head of Corp. Strategy & Devel.

Who are some of C4X Discovery's key competitors?

What other stocks do shareholders of C4X Discovery own?

Based on aggregate information from My MarketBeat watchlists, some companies that other C4X Discovery investors own include Rio Tinto Group (RIO), Ryder System (R), Pearson (PSON), Moss Bros Group (MOSB), (ITX) (ITX), Inland Homes (INL), Fundsmith Emerging Equities Trust (FEET), easyJet (EZJ), Card Factory (CARD) and The Berkeley Group (BKG).

What is C4X Discovery's stock symbol?

C4X Discovery trades on the London Stock Exchange (LON) under the ticker symbol "C4XD."

How do I buy shares of C4X Discovery?

Shares of C4XD and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is C4X Discovery's stock price today?

One share of C4XD stock can currently be purchased for approximately GBX 31.50.

How much money does C4X Discovery make?

C4X Discovery has a market capitalization of £71.41 million and generates £7.06 million in revenue each year.

How many employees does C4X Discovery have?

C4X Discovery employs 46 workers across the globe.

What is C4X Discovery's official website?

The official website for C4X Discovery is www.c4xdiscovery.com.

Where are C4X Discovery's headquarters?

C4X Discovery is headquartered at 53 Portland Street, MANCHESTER, M1 3LD, United Kingdom.

How can I contact C4X Discovery?

C4X Discovery's mailing address is 53 Portland Street, MANCHESTER, M1 3LD, United Kingdom. The company can be reached via phone at +44-161-2355085.

This page was last updated on 8/3/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.